000			02074 a2200589 4500
005			20250516151833.0
264		0	_c20140204
008			201402s 0 0 eng d
022			_a1365-2141
024	7		_a10.1111/bjh.12361 _2doi
040			_aNLM _beng _cNLM
100	1		_aPönisch, Wolfram
245	0	0	_aLenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. _h[electronic resource]
260			_bBritish journal of haematology _cJul 2013
300			_a202-9 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBendamustine Hydrochloride
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLenalidomide
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aNitrogen Mustard Compounds _xadministration & dosage
650	0	4	_aPrednisolone _xadministration & dosage
650	0	4	_aRecurrence
650	0	4	_aThalidomide _xadministration & dosage
700	1		_aHeyn, Simone
700	1		_aBeck, Juliane
700	1		_aWagner, Ina
700	1		_aMohren, Martin
700	1		_aHoffmann, Franz A
700	1		_aLange, Thoralf
700	1		_aSchmalfeld, Marion
700	1		_aZehrfeld, Thomas
700	1		_aSchwarzer, Andreas
700	1		_aWinkelmann, Cornelia
700	1		_aEdelmann, Thomas
700	1		_aRöhrborn, Ramona
700	1		_aHebenstreit, Karin
700	1		_aAl-Ali, Haifa K
700	1		_aJäkel, Nadja
700	1		_aNiederwieser, Dietger
773	0		_tBritish journal of haematology _gvol. 162 _gno. 2 _gp. 202-9
856	4	0	_uhttps://doi.org/10.1111/bjh.12361 _zAvailable from publisher's website
999			_c22769138 _d22769138